Shuttle Pharmaceuticals Files S-1 for Securities Registration

Ticker: SHPH · Form: S-1 · Filed: Feb 13, 2025 · CIK: 1757499

Shuttle Pharmaceuticals Holdings, Inc. S-1 Filing Summary
FieldDetail
CompanyShuttle Pharmaceuticals Holdings, Inc. (SHPH)
Form TypeS-1
Filed DateFeb 13, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$0.00001, $0, $0.001, $0.704
Sentimentneutral

Sentiment: neutral

Topics: S-1, registration-statement, pharmaceuticals

TL;DR

Shuttle Pharma just filed an S-1, get ready for potential stock action.

AI Summary

Shuttle Pharmaceuticals Holdings, Inc. filed an S-1 form on February 13, 2025, to register securities. The company, based in Gaithersburg, MD, operates in the pharmaceutical preparations sector. This filing indicates a step towards a potential public offering or other securities-related transactions.

Why It Matters

This S-1 filing is a crucial step for Shuttle Pharmaceuticals, signaling their intent to engage with public markets, which could lead to significant funding or strategic partnerships.

Risk Assessment

Risk Level: medium — S-1 filings are often precursors to IPOs or significant capital raises, which inherently carry market and execution risks.

Key Numbers

  • 20250213 — Filing Date (Indicates the date the S-1 was submitted to the SEC.)
  • 333-284889 — SEC File Number (Unique identifier for this filing with the SEC.)

Key Players & Entities

  • Shuttle Pharmaceuticals Holdings, Inc. (company) — Filer of the S-1 document
  • 20250213 (date) — Filing date of the S-1
  • Gaithersburg, MD (location) — Company's business address
  • 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations

FAQ

What is the primary purpose of this S-1 filing for Shuttle Pharmaceuticals Holdings, Inc.?

The S-1 filing is a registration statement filed with the SEC, typically to register securities for a public offering or other transactions involving the sale of securities.

When was this S-1 filing submitted?

The filing was submitted on February 13, 2025.

Where is Shuttle Pharmaceuticals Holdings, Inc. located?

The company's business and mailing address is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.

What industry does Shuttle Pharmaceuticals Holdings, Inc. operate in?

The company is classified under Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.

What is the SEC file number associated with this filing?

The SEC file number is 333-284889.

Filing Stats: 4,497 words · 18 min read · ~15 pages · Grade level 15.2 · Accepted 2025-02-13 06:22:07

Key Financial Figures

  • $0.00001 — he "Shares") of common stock, par value $0.00001 per share ("common stock") or pre-funde
  • $0 — d to the public in this offering, minus $0.001, and the exercise price of each Pre
  • $0.001 — rice of each Pre-Funded Warrant will be $0.001 per share. The Pre-Funded Warrants will
  • $0.704 — rted sale price of our common stock was $0.704 per share. We have retained WestPark

Filing Documents

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 62 MANAGEMENT 74 EXECUTIVE AND DIRECTOR COMPENSATION 83 BENEFICIAL OWNERSHIP OF SECURITIES 86 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 87 CAPITALIZATION 88

DILUTION

DILUTION 89 DIVIDEND POLICY 9 0 DESCRIPTION OF CAPITAL STOCK 90 DESCRIPTION OF SECURITIES WE ARE OFFERING 95

UNDERWRITING

UNDERWRITING 97 LEGAL MATTERS 98 EXPERTS 98 WHERE YOU CAN FIND MORE INFORMATION 98 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS The registration statement of which this prospectus forms a part and which we filed with the Securities and Exchange Commission (the "SEC") includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the heading "Where You Can Find More Information" before making your investment decision. You should rely only on the information provided in this prospectus, in any prospectus supplement or in a related free writing prospectus, or documents to which we otherwise refer you. In addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. This prospectus includes important information about us, the securities being offered and other information you should know before investing in our securities. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus, even though this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus in making your investment decision. All of the summaries in this prospectus are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading "Where You Can Find More Information." We have not, and the Underwri

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.